A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma

Clinical trial NCT00925314 · UNKNOWN

Trial details

NCT number: NCT00925314
Sponsor: Cosmo Bioscience
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma

Start date: 2007-06-01
Primary completion: 2011-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.